Immuno-Oncology Cell Assay Services

Creative Biolabs provides clear and actionable solutions for your immuno-oncology projects, helping you validate your therapeutic's mechanism of action, optimize lead candidates, and assess potential toxicity. Our capabilities are specifically designed to address key challenges in the field, such as therapeutic resistance and the complex interplay between immune cells and tumor cells. We help you move beyond simple viability assays to obtain a holistic understanding of your candidate's biological activity in a physiologically relevant context.

Unlocking Immuno-oncology

Immuno-oncology is a transformative field that leverages the power of the body's immune system to fight cancer. The central challenge lies in understanding how to "unmask" tumors that have evolved mechanisms to evade immune attack. Immuno-oncology cell-based assays are essential for studying these complex interactions, bridging the gap between theoretical drug design and clinical application. By providing a platform for early drug discovery and validation, these assays are crucial for identifying promising candidates and de-risking the development pipeline.

Discover how we can help - Request a consultation.

Fig.1 The Immune system can eliminate tumor cells by self-sustaining and self-restricting feedback loops.¹

What We Can Offer

Creative Biolabs has over a decade of proven expertise in the research of cell-based assays. Our service offering comprises full cell-based assay analytical methods.

Types of our Immuno-oncology Cell Assay Services

Applications of Cell Assay for Drug Discovery

High-throughput screening (HTS) has been widely applied in discovery and drug development, which is a challenging process characterized by expense and time-consuming, full of failures. Cell-based assays have been integrated with HTS technologies, which are unable to reflect the complexity of living systems. To address this problem, in vitro cell culture models are used to get substantive information on various cellular responses to a compound. Combining advanced microscopy with cell-based assays can monitor both spatial and temporal resolution, which has driven the development of HCS technologies. Cell assays can accelerate and enhance the process of drug identification and development to help new therapeutics be brought to market in an efficient manner.

Blew is HCS-compatible, biochemical, and molecular biology-driven assays for drug discovery, which are available at Creative Biolabs.

Discover how a partnership with us can streamline your research - Get a quote today.

Customer Reviews

• Exceptional Reliability
  Using Creative Biolabs' immuno-oncology cell assay services in our research has significantly improved the reliability of our early-stage screening. The data is consistently clean, and their reports are incredibly thorough. - J*an.
• Unmatched Expertise
  Their team's deep understanding of resistance mechanisms and predictive biomarkers was a game-changer for our project. They provided a level of scientific consultation that goes far beyond a typical service provider. - M*ly.

FAQs

Related Services

How to Contact Us

Creative Biolabs provides a comprehensive array of validated cell-based assays and full support for drug development. We work with our clients to come up with the best assay for the proposal. Please contact us for more detailed information on cell-based assays.

Reference

1. Li, Su-Ran et al. "Recent advances in porous nanomaterials-based drug delivery systems for cancer immunotherapy." Journal of nanobiotechnology vol. 20,1 277. 14 Jun. 2022. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.1186/s12951-022-01489-4

Download our brochure